1. An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation. (July 2022) Authors: Puth, Sao; Verma, Vivek; Hong, Seol Hee; Tan, Wenzhi; Lee, Shee Eun; Rhee, Joon Haeng Journal: Biomaterials Issue: Volume 286(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis. Issue 9 (14th September 2022) Authors: Zhang, Zhijian; Mo, Yanping; Wu, Lixuan; Wang, Xiaolong; Liao, Guansheng; Tan, Wenzhi; Li, Dexiang Journal: Anti-cancer drugs Issue: Volume 33:Issue 9(2022) Page Start: 923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics. (1st April 2021) Authors: Chen, Yu; Liu, Xiaoqing; Guo, Yanxia; Wang, Jianchuan; Zhang, Dingxiao; Mei, Yang; Shi, Junfeng; Tan, Wenzhi; Zheng, Jin Hai Journal: Acta biomaterialia Issue: Volume 124(2021) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization. Issue 9 (2nd September 2018) Authors: Hwang, Hye Suk; Puth, Sao; Tan, Wenzhi; Verma, Vivek; Jeong, Kwangjoon; Lee, Shee Eun; Rhee, Joon Haeng Journal: Human vaccines & immunotherapeutics Issue: Volume 14:Issue 9(2018) Page Start: 2194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB. Issue 1 (December 2016) Authors: Verma, Vivek; Tan, Wenzhi; Puth, Sao; Cho, Kyoung-Oh; Lee, Shee; Rhee, Joon Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium. (28th January 2020) Authors: Guo, Yanxia; Chen, Yu; Liu, Xiaoqing; Min, Jung-Joon; Tan, Wenzhi; Zheng, Jin Hai Journal: Cancer letters Issue: Volume 469(2020) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The cytochrome d oxidase complex regulated by fexA is an Achilles' heel in the in vivo survival of vibrio vulnificus. Issue 1 (1st January 2019) Authors: Tan, Wenzhi; Jeong, Kwangjoon; Pendru, Raghunath; Puth, Sao; Hong, Seol Hee; Lee, Shee Eun; Rhee, Joon Haeng Journal: Emerging microbes & infections Issue: Volume 8:Issue 1(2019) Page Start: 1406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The cytochrome d oxidase complex regulated by fexA is an Achilles' heel in the in vivo survival of Vibrio vulnificus. Issue 1 (1st January 2019) Authors: Tan, Wenzhi; Jeong, Kwangjoon; Pendru, Raghunath; Puth, Sao; Hong, Seol Hee; Lee, Shee Eun; Rhee, Joon Haeng Journal: Emerging microbes & infections Issue: Volume 8:Issue 1(2019) Page Start: 1406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗